A Phase I Clinical Trial of Vaccination With KIF20A-derived Peptide in Combination With Gemcitabine For Patients With Advanced Pancreatic Cancer

KIF20A (RAB6KIFL) belongs to the kinesin superfamily of motor proteins, which play critical roles in the trafficking of molecules and organelles during the growth of pancreatic cancer. Immunotherapy using a previously identified epitope peptide for KIF20A is expected to improve clinical outcomes. A...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Suzuki, Nobuaki, Hazama, Shoichi, Ueno, Tomio, Matsui, Hiroto, Shindo, Yoshitaro, Iida, Michihisa, Yoshimura, Kiyoshi, Yoshino, Shigefumi, Takeda, Kazuyoshi, Oka, Masaaki
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Lippincott Williams & Wilkins 2014
Konular:
Clinical Studies
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3868021/
https://ncbi.nlm.nih.gov/pubmed/24316554
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CJI.0000000000000012
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller